APO Research

APO RESEARCH · REPORT

Neohesperidoside

Selected research

Market Structure

Global Neohesperidoside Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Neohesperidoside market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neohesperidoside is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neohesperidoside include Biospringer, DowDuPont, BASF SE, FMC Health and Nutrition, Firmenich SA, Edlong Dairy Technologies, CP Kelco, Corbion NV and Chr.Hansen Holding A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Neohesperidoside output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Neohesperidoside by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Neohesperidoside market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neohesperidoside and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neohesperidoside sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neohesperidoside market size, projected growth trends, production technologies, key applications, and end-use industries.

Neohesperidoside Segment by Company

Biospringer

DowDuPont

BASF SE

FMC Health and Nutrition

Firmenich SA

Edlong Dairy Technologies

CP Kelco

Corbion NV

Chr.Hansen Holding A/S

Cargill

Neohesperidoside Segment by Type

Pharmacy Grade

Food Grade

Industrial Grade

Neohesperidoside Segment by Application

Cosmetics

Food

Medicine

Neohesperidoside Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neohesperidoside market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neohesperidoside and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neohesperidoside.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neohesperidoside market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neohesperidoside industry.

Chapter 3: Detailed analysis of Neohesperidoside market competition landscape. Including Neohesperidoside manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Neohesperidoside by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Neohesperidoside in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Neohesperidoside Industry Trends Table 2. Neohesperidoside Industry Drivers Table 3. Neohesperidoside Industry Opportunities and Challenges Table 4. Neohesperidoside Industry Restraints Table 5. Global Neohesperidoside Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neohesperidoside Production Value Share by Manufacturers (2021-2026) Table 7. Global Neohesperidoside Production by Manufacturers (t) & (2021-2026) Table 8. Global Neohesperidoside Production Market Share by Manufacturers Table 9. Global Neohesperidoside Average Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Neohesperidoside Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neohesperidoside Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neohesperidoside Manufacturers, Product Type & Application Table 13. Global Neohesperidoside Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neohesperidoside by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Pharmacy Grade Table 17. Major Manufacturers of Food Grade Table 18. Major Manufacturers of Industrial Grade Table 19. Global Neohesperidoside Production by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Neohesperidoside Production by Type (2021-2026) & (t) Table 21. Global Neohesperidoside Production by Type (2027-2032) & (t) Table 22. Global Neohesperidoside Production Market Share by Type (2021-2026) Table 23. Global Neohesperidoside Production Market Share by Type (2027-2032) Table 24. Global Neohesperidoside Production Value by Type 2021 VS 2025 VS 2032 (t) Table 25. Global Neohesperidoside Production Value by Type (2021-2026) & (t) Table 26. Global Neohesperidoside Production Value by Type (2027-2032) & (t) Table 27. Global Neohesperidoside Production Value Market Share by Type (2021-2026) Table 28. Global Neohesperidoside Production Value Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cosmetics Table 30. Major Manufacturers of Food Table 31. Major Manufacturers of Medicine Table 32. Global Neohesperidoside Production by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Neohesperidoside Production by Application (2021-2026) & (t) Table 34. Global Neohesperidoside Production by Application (2027-2032) & (t) Table 35. Global Neohesperidoside Production Market Share by Application (2021-2026) Table 36. Global Neohesperidoside Production Market Share by Application (2027-2032) Table 37. Global Neohesperidoside Production Value by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Neohesperidoside Production Value by Application (2021-2026) & (t) Table 39. Global Neohesperidoside Production Value by Application (2027-2032) & (t) Table 40. Global Neohesperidoside Production Value Market Share by Application (2021-2026) Table 41. Global Neohesperidoside Production Value Market Share by Application (2027-2032) Table 42. Biospringer Company Information Table 43. Biospringer Business Overview Table 44. Biospringer Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Biospringer Neohesperidoside Product Portfolio Table 46. Biospringer Recent Development Table 47. DowDuPont Company Information Table 48. DowDuPont Business Overview Table 49. DowDuPont Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 50. DowDuPont Neohesperidoside Product Portfolio Table 51. DowDuPont Recent Development Table 52. BASF SE Company Information Table 53. BASF SE Business Overview Table 54. BASF SE Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 55. BASF SE Neohesperidoside Product Portfolio Table 56. BASF SE Recent Development Table 57. FMC Health and Nutrition Company Information Table 58. FMC Health and Nutrition Business Overview Table 59. FMC Health and Nutrition Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 60. FMC Health and Nutrition Neohesperidoside Product Portfolio Table 61. FMC Health and Nutrition Recent Development Table 62. Firmenich SA Company Information Table 63. Firmenich SA Business Overview Table 64. Firmenich SA Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. Firmenich SA Neohesperidoside Product Portfolio Table 66. Firmenich SA Recent Development Table 67. Edlong Dairy Technologies Company Information Table 68. Edlong Dairy Technologies Business Overview Table 69. Edlong Dairy Technologies Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Edlong Dairy Technologies Neohesperidoside Product Portfolio Table 71. Edlong Dairy Technologies Recent Development Table 72. CP Kelco Company Information Table 73. CP Kelco Business Overview Table 74. CP Kelco Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. CP Kelco Neohesperidoside Product Portfolio Table 76. CP Kelco Recent Development Table 77. Corbion NV Company Information Table 78. Corbion NV Business Overview Table 79. Corbion NV Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Corbion NV Neohesperidoside Product Portfolio Table 81. Corbion NV Recent Development Table 82. Chr.Hansen Holding A/S Company Information Table 83. Chr.Hansen Holding A/S Business Overview Table 84. Chr.Hansen Holding A/S Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Chr.Hansen Holding A/S Neohesperidoside Product Portfolio Table 86. Chr.Hansen Holding A/S Recent Development Table 87. Cargill Company Information Table 88. Cargill Business Overview Table 89. Cargill Neohesperidoside Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Cargill Neohesperidoside Product Portfolio Table 91. Cargill Recent Development Table 92. Global Neohesperidoside Production by Region: 2021 VS 2025 VS 2032 (t) Table 93. Global Neohesperidoside Production by Region (2021-2026) & (t) Table 94. Global Neohesperidoside Production Market Share by Region (2021-2026) Table 95. Global Neohesperidoside Production Forecast by Region (2027-2032) & (t) Table 96. Global Neohesperidoside Production Market Share Forecast by Region (2027-2032) Table 97. Global Neohesperidoside Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Global Neohesperidoside Production Value by Region (2021-2026) & (US$ Million) Table 99. Global Neohesperidoside Production Value Share by Region (2021-2026) Table 100. Global Neohesperidoside Production Value by Region (2027-2032) & (US$ Million) Table 101. Global Neohesperidoside Production Value Share by Region: (2027-2032) & (US$ Million) Table 102. Global Neohesperidoside Market Average Price (USD/t) by Region (2021-2026) Table 103. Global Neohesperidoside Market Average Price (USD/t) by Region (2027-2032) Table 104. Global Neohesperidoside Consumption by Region: 2021 VS 2025 VS 2032 (t) Table 105. Global Neohesperidoside Consumption by Region (2021-2026) & (t) Table 106. Global Neohesperidoside Consumption Market Share by Region (2021-2026) Table 107. Global Neohesperidoside Consumption Forecasted by Region (2027-2032) & (t) Table 108. Global Neohesperidoside Consumption Forecasted Market Share by Region (2027-2032) Table 109. North America Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 110. North America Neohesperidoside Consumption by Country (2021-2026) & (t) Table 111. North America Neohesperidoside Consumption by Country (2027-2032) & (t) Table 112. Europe Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 113. Europe Neohesperidoside Consumption by Country (2021-2026) & (t) Table 114. Europe Neohesperidoside Consumption by Country (2027-2032) & (t) Table 115. Asia Pacific Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 116. Asia Pacific Neohesperidoside Consumption by Country (2021-2026) & (t) Table 117. Asia Pacific Neohesperidoside Consumption by Country (2027-2032) & (t) Table 118. South America Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 119. South America Neohesperidoside Consumption by Country (2021-2026) & (t) Table 120. South America Neohesperidoside Consumption by Country (2027-2032) & (t) Table 121. Middle East & Africa Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 122. Middle East & Africa Neohesperidoside Consumption by Country (2021-2026) & (t) Table 123. Middle East & Africa Neohesperidoside Consumption by Country (2027-2032) & (t) Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Neohesperidoside Distributors List Table 127. Neohesperidoside Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Neohesperidoside Product Image Figure 2. Global Neohesperidoside Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 4. Global Neohesperidoside Production Capacity (2021-2032) & (t) Figure 5. Global Neohesperidoside Production (2021-2032) & (t) Figure 6. Global Neohesperidoside Average Price (USD/t) & (2021-2032) Figure 7. Global Top 5 and 10 Neohesperidoside Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pharmacy Grade Image Figure 10. Food Grade Image Figure 11. Industrial Grade Image Figure 12. Global Neohesperidoside Production by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Neohesperidoside Production Market Share 2021 VS 2025 VS 2032 Figure 14. Global Neohesperidoside Production Market Share by Type (2021-2032) Figure 15. Global Neohesperidoside Production Value by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Neohesperidoside Production Value Share 2021 VS 2025 VS 2032 Figure 17. Global Neohesperidoside Production Value Share by Type (2021-2032) Figure 18. Cosmetics Image Figure 19. Food Image Figure 20. Medicine Image Figure 21. Global Neohesperidoside Production by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Neohesperidoside Production Market Share 2021 VS 2025 VS 2032 Figure 23. Global Neohesperidoside Production Market Share by Application (2021-2032) Figure 24. Global Neohesperidoside Production Value by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Neohesperidoside Production Value Share 2021 VS 2025 VS 2032 Figure 26. Global Neohesperidoside Production Value Share by Application (2021-2032) Figure 27. Global Neohesperidoside Production by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Neohesperidoside Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Neohesperidoside Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Neohesperidoside Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 32. Europe Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 34. South America Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Neohesperidoside Production Value (2021-2032) & (US$ Million) Figure 36. North America Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 37. North America Neohesperidoside Consumption Market Share by Country (2021-2032) Figure 38. U.S. Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 39. Canada Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 40. Mexico Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 41. Europe Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 42. Europe Neohesperidoside Consumption Market Share by Country (2021-2032) Figure 43. Germany Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 44. France Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 45. U.K. Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 46. Italy Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 47. Netherlands Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 48. Asia Pacific Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 49. Asia Pacific Neohesperidoside Consumption Market Share by Country (2021-2032) Figure 50. China Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 51. Japan Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 52. South Korea Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 53. Southeast Asia Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 54. India Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 55. Australia Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 56. South America Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 57. South America Neohesperidoside Consumption Market Share by Country (2021-2032) Figure 58. Brazil Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 59. Argentina Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 60. Chile Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 61. Middle East & Africa Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 62. Middle East & Africa Neohesperidoside Consumption Market Share by Country (2021-2032) Figure 63. Egypt Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 64. South Africa Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 65. Israel Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 66. Türkiye Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 67. GCC Countries Neohesperidoside Consumption and Growth Rate (2021-2032) & (t) Figure 68. Neohesperidoside Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Neohesperidoside Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmacy Grade
  • Food Grade
  • Industrial Grade
Applications
  • Cosmetics
  • Food
  • Medicine
Companies covered
  • Biospringer
  • DowDuPont
  • BASF SE
  • FMC Health and Nutrition
  • Firmenich SA
  • Edlong Dairy Technologies
  • CP Kelco
  • Corbion NV
  • Chr.Hansen Holding A/S
  • Cargill

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neohesperidoside Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Neohesperidoside Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Neohesperidoside Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Neohesperidoside Market Dynamics
  1. 2.1 Neohesperidoside Industry Trends
  2. 2.2 Neohesperidoside Industry Drivers
  3. 2.3 Neohesperidoside Industry Opportunities and Challenges
  4. 2.4 Neohesperidoside Industry Restraints
3 Neohesperidoside Market by Manufacturers
  1. 3.1 Global Neohesperidoside Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Neohesperidoside Production by Manufacturers (2021-2026)
  3. 3.3 Global Neohesperidoside Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Neohesperidoside Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neohesperidoside Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neohesperidoside Manufacturers, Product Type & Application
  7. 3.7 Global Neohesperidoside Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neohesperidoside Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neohesperidoside Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Neohesperidoside Tier 1, Tier 2, and Tier 3
4 Neohesperidoside Market by Type
  1. 4.1 Neohesperidoside Type Introduction
  2. 4.1.1 Pharmacy Grade
  3. 4.1.2 Food Grade
  4. 4.1.3 Industrial Grade
  5. 4.2 Global Neohesperidoside Production by Type
  6. 4.2.1 Global Neohesperidoside Production by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neohesperidoside Production by Type (2021-2032)
  8. 4.2.3 Global Neohesperidoside Production Market Share by Type (2021-2032)
  9. 4.3 Global Neohesperidoside Production Value by Type
  10. 4.3.1 Global Neohesperidoside Production Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Neohesperidoside Production Value by Type (2021-2032)
  12. 4.3.3 Global Neohesperidoside Production Value Market Share by Type (2021-2032)
5 Neohesperidoside Market by Application
  1. 5.1 Neohesperidoside Application Introduction
  2. 5.1.1 Cosmetics
  3. 5.1.2 Food
  4. 5.1.3 Medicine
  5. 5.2 Global Neohesperidoside Production by Application
  6. 5.2.1 Global Neohesperidoside Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neohesperidoside Production by Application (2021-2032)
  8. 5.2.3 Global Neohesperidoside Production Market Share by Application (2021-2032)
  9. 5.3 Global Neohesperidoside Production Value by Application
  10. 5.3.1 Global Neohesperidoside Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neohesperidoside Production Value by Application (2021-2032)
  12. 5.3.3 Global Neohesperidoside Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Biospringer
  2. 6.1.1 Biospringer Company Information
  3. 6.1.2 Biospringer Business Overview
  4. 6.1.3 Biospringer Neohesperidoside Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Biospringer Neohesperidoside Product Portfolio
  6. 6.1.5 Biospringer Recent Developments
  7. 6.2 DowDuPont
  8. 6.2.1 DowDuPont Company Information
  9. 6.2.2 DowDuPont Business Overview
  10. 6.2.3 DowDuPont Neohesperidoside Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 DowDuPont Neohesperidoside Product Portfolio
  12. 6.2.5 DowDuPont Recent Developments
  13. 6.3 BASF SE
  14. 6.3.1 BASF SE Company Information
  15. 6.3.2 BASF SE Business Overview
  16. 6.3.3 BASF SE Neohesperidoside Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 BASF SE Neohesperidoside Product Portfolio
  18. 6.3.5 BASF SE Recent Developments
  19. 6.4 FMC Health and Nutrition
  20. 6.4.1 FMC Health and Nutrition Company Information
  21. 6.4.2 FMC Health and Nutrition Business Overview
  22. 6.4.3 FMC Health and Nutrition Neohesperidoside Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 FMC Health and Nutrition Neohesperidoside Product Portfolio
  24. 6.4.5 FMC Health and Nutrition Recent Developments
  25. 6.5 Firmenich SA
  26. 6.5.1 Firmenich SA Company Information
  27. 6.5.2 Firmenich SA Business Overview
  28. 6.5.3 Firmenich SA Neohesperidoside Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Firmenich SA Neohesperidoside Product Portfolio
  30. 6.5.5 Firmenich SA Recent Developments
  31. 6.6 Edlong Dairy Technologies
  32. 6.6.1 Edlong Dairy Technologies Company Information
  33. 6.6.2 Edlong Dairy Technologies Business Overview
  34. 6.6.3 Edlong Dairy Technologies Neohesperidoside Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Edlong Dairy Technologies Neohesperidoside Product Portfolio
  36. 6.6.5 Edlong Dairy Technologies Recent Developments
  37. 6.7 CP Kelco
  38. 6.7.1 CP Kelco Company Information
  39. 6.7.2 CP Kelco Business Overview
  40. 6.7.3 CP Kelco Neohesperidoside Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 CP Kelco Neohesperidoside Product Portfolio
  42. 6.7.5 CP Kelco Recent Developments
  43. 6.8 Corbion NV
  44. 6.8.1 Corbion NV Company Information
  45. 6.8.2 Corbion NV Business Overview
  46. 6.8.3 Corbion NV Neohesperidoside Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Corbion NV Neohesperidoside Product Portfolio
  48. 6.8.5 Corbion NV Recent Developments
  49. 6.9 Chr.Hansen Holding A/S
  50. 6.9.1 Chr.Hansen Holding A/S Company Information
  51. 6.9.2 Chr.Hansen Holding A/S Business Overview
  52. 6.9.3 Chr.Hansen Holding A/S Neohesperidoside Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Chr.Hansen Holding A/S Neohesperidoside Product Portfolio
  54. 6.9.5 Chr.Hansen Holding A/S Recent Developments
  55. 6.10 Cargill
  56. 6.10.1 Cargill Company Information
  57. 6.10.2 Cargill Business Overview
  58. 6.10.3 Cargill Neohesperidoside Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Cargill Neohesperidoside Product Portfolio
  60. 6.10.5 Cargill Recent Developments
7 Global Neohesperidoside Production by Region
  1. 7.1 Global Neohesperidoside Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Neohesperidoside Production by Region (2021-2032)
  3. 7.2.1 Global Neohesperidoside Production by Region (2021-2026)
  4. 7.2.2 Global Neohesperidoside Production Forecast by Region (2027-2032)
  5. 7.3 Global Neohesperidoside Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Neohesperidoside Production Value by Region (2021-2032)
  7. 7.4.1 Global Neohesperidoside Production Value by Region (2021-2026)
  8. 7.4.2 Global Neohesperidoside Production Value by Region (2027-2032)
  9. 7.5 Global Neohesperidoside Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Neohesperidoside Production Value (2021-2032)
  12. 7.6.2 Europe Neohesperidoside Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Neohesperidoside Production Value (2021-2032)
  14. 7.6.4 South America Neohesperidoside Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Neohesperidoside Production Value (2021-2032)
8 Global Neohesperidoside Consumption by Region
  1. 8.1 Global Neohesperidoside Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Neohesperidoside Consumption by Region (2021-2032)
  3. 8.2.1 Global Neohesperidoside Consumption by Region (2021-2026)
  4. 8.2.2 Global Neohesperidoside Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Neohesperidoside Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Neohesperidoside Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Neohesperidoside Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Neohesperidoside Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Neohesperidoside Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neohesperidoside Value Chain Analysis
  2. 9.1.1 Neohesperidoside Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neohesperidoside Production Mode & Process
  6. 9.2 Neohesperidoside Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neohesperidoside Distributors
  9. 9.2.3 Neohesperidoside Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research